• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018 年,在四个州的医疗补助计划中,青少年和年轻人开始接受阿片类药物使用障碍治疗药物的比例:提高医疗补助质量指标。

Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics.

机构信息

The Urban Institute, Washington, DC, USA.

出版信息

Subst Use Addctn J. 2024 Jul;45(3):434-445. doi: 10.1177/29767342241227791. Epub 2024 Jan 31.

DOI:10.1177/29767342241227791
PMID:38294428
Abstract

BACKGROUND

Medications for opioid use disorder (MOUD) in youth can reduce harms but many youths do not receive MOUD. Improving quality metrics of MOUD among youth can advance interventions for youth with opioid use disorder (OUD).

METHODS

We relied on 2018 Medicaid claims data from California, Colorado, Massachusetts, and New Mexico. We calculated the percentage of youth with OUD included in the quality metric for initiation, and the percentage who initiated by state. We also calculated the percentage excluded from the quality metric for initiation because they have an existing episode of OUD care and their MOUD receipt. We compared the characteristics of those who initiated/received MOUD to those who did not and compared state estimates after adjusting for age and health conditions.

RESULTS

Estimates of initiation exclude about half of the youth with OUD because they were in an existing episode of OUD care and could not be observed initiating. Among youth in a new episode of OUD care, only about 1 in 4 initiated and state estimates varied from 18.9% to 40.1%. Among youth with an existing episode of OUD care, more than half received MOUD and state estimates ranged from 35.2% to 71.3%. Youth who initiated MOUD or received MOUD with an existing OUD had more severe OUD but fewer co-occurring substance use disorders or mental or physical health diagnoses. After adjusting for age and health conditions, MOUD still varied substantially across states.

CONCLUSIONS

Most youth with a new OUD diagnosis do not initiate MOUD but more than half of the youth in an existing OUD diagnosis receive MOUD. MOUD quality metrics that are disaggregated, adjusted, and inclusive of youth in an existing episode of care provide additional insight into opportunities to better support youth who might choose MOUD. State differences should be further studied for insight into policies that may affect MOUD.

摘要

背景

青少年阿片类药物使用障碍(MOUD)的药物治疗可以减少危害,但许多青少年并未接受 MOUD。提高青少年 MOUD 的质量指标可以促进针对阿片类药物使用障碍(OUD)青少年的干预措施。

方法

我们依赖于来自加利福尼亚州、科罗拉多州、马萨诸塞州和新墨西哥州的 2018 年医疗补助索赔数据。我们计算了纳入启动质量指标的 OUD 青少年的百分比,以及按州启动的百分比。我们还计算了因存在 OUD 护理的现有发作以及他们的 MOUD 接收而被排除在启动质量指标之外的百分比。我们比较了启动/接受 MOUD 的青少年的特征与未启动/接受 MOUD 的青少年的特征,并在调整年龄和健康状况后比较了州估计值。

结果

启动的估计数排除了大约一半的 OUD 青少年,因为他们处于 OUD 护理的现有发作中,无法观察到他们开始接受治疗。在新发作的 OUD 护理中,只有大约 1/4 的人开始接受治疗,州估计值从 18.9%到 40.1%不等。在存在 OUD 护理的现有发作的青少年中,超过一半的人接受了 MOUD,州估计值从 35.2%到 71.3%不等。启动 MOUD 或在现有 OUD 诊断中接受 MOUD 的青少年的 OUD 更为严重,但共病物质使用障碍或精神或身体健康诊断较少。在调整年龄和健康状况后,各州之间的 MOUD 仍存在很大差异。

结论

大多数新诊断出 OUD 的青少年并未开始接受 MOUD,但超过一半的青少年在现有的 OUD 诊断中接受 MOUD。针对现有护理发作中的青少年进行分类、调整和包容的 MOUD 质量指标为更好地支持可能选择 MOUD 的青少年提供了更多的见解。应进一步研究各州之间的差异,以了解可能影响 MOUD 的政策。

相似文献

1
Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics.2018 年,在四个州的医疗补助计划中,青少年和年轻人开始接受阿片类药物使用障碍治疗药物的比例:提高医疗补助质量指标。
Subst Use Addctn J. 2024 Jul;45(3):434-445. doi: 10.1177/29767342241227791. Epub 2024 Jan 31.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder by Race and Ethnicity and Insurance Type.按种族、民族和保险类型划分的丁丙诺啡和纳曲酮用于阿片类物质使用障碍的情况
JAMA Netw Open. 2025 Jun 2;8(6):e2518493. doi: 10.1001/jamanetworkopen.2025.18493.
4
The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder.阿片类药物使用障碍治疗研究:18 个月阿片类药物使用障碍治疗患者的研究方法和初步结果。
Public Health Rep. 2024 Jul-Aug;139(4):484-493. doi: 10.1177/00333549231222479. Epub 2024 Jan 25.
5
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.州许可的专业物质使用治疗计划中使用丁丙诺啡的障碍和促进因素:对项目领导层的调查。
J Subst Use Addict Treat. 2024 Jul;162:209351. doi: 10.1016/j.josat.2024.209351. Epub 2024 Mar 17.
6
Medications for Opioid Use Disorder After Entering Residential Treatment: Evidence From Louisiana Medicaid.进入住院治疗后用于阿片类物质使用障碍的药物:来自路易斯安那州医疗补助计划的证据。
J Addict Med. 2025;19(1):47-52. doi: 10.1097/ADM.0000000000001373. Epub 2024 Aug 16.
7
Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder.患者和提供者的药物偏好会影响患有阿片类药物使用障碍的青少年和年轻人的治疗结果。
J Subst Use Addict Treat. 2024 Jul;162:209334. doi: 10.1016/j.josat.2024.209334. Epub 2024 Mar 24.
8
Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder.感知可及性和治疗知识对阿片类药物使用障碍药物治疗偏好的影响。
Subst Use Addctn J. 2024 Oct;45(4):706-715. doi: 10.1177/29767342241254591. Epub 2024 Jun 3.
9
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.
10
Survey of barriers and opportunities for prescribing buprenorphine for opioid use disorder in Alabama.阿拉巴马州阿片类药物使用障碍患者开处丁丙诺啡处方的障碍和机会调查。
J Addict Dis. 2024 Oct-Dec;42(4):410-417. doi: 10.1080/10550887.2023.2247950. Epub 2023 Aug 31.

引用本文的文献

1
Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018-2023: Current Status, Best Practices, and Opportunities for Advancing the Science.青少年物质使用门诊行为治疗的循证依据,2018 - 2023年更新:现状、最佳实践及推动该科学发展的机遇
J Clin Child Adolesc Psychol. 2025 Aug 4:1-25. doi: 10.1080/15374416.2025.2521855.
2
Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.探究美国接受药物辅助治疗的青少年完成治疗的决定因素。
Healthcare (Basel). 2025 Apr 2;13(7):798. doi: 10.3390/healthcare13070798.